David Rorie

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

Isla S. Mackenzie, Amy Rogers, Neil R Poulter et al. · The Lancet · 2022 · 203 citations · Full text

Blood Pressure Monitoring, Hypertension, Health Policy +10

Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study

David Rorie, Amy Rogers, Isla S. Mackenzie et al. · BMJ Open · 2016 · 64 citations · Full text

Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study

Filippo Pigazzani, Kenneth A. Dyar, S. V. Morant et al. · EClinicalMedicine · 2024 · 23 citations · Full text

The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment

David Rorie, Robert Flynn, Isla S. Mackenzie et al. · Trials · 2017 · 21 citations · Full text

Factors influencing home blood pressure monitor ownership in a large clinical trial

Thineskrishna Anbarasan, Amy Rogers, David Rorie et al. · Journal of Human Hypertension · 2021 · 12 citations · Full text